NCT03128008
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,258 public trials
1,193 recruiting studies
Carcinoma, Bronchogenic trial results
NCT02777658
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Research Site Aschaffenburg, Germany
- Research Site Augsburg, Germany
- Research Site Bad Kreuznach, Germany
- Research Site Ballenstedt, Germany
Completed
Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies
NCT03607149
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- CH William Morey Chalon-sur-Saône, France
- Centre Georges Francois Leclerc Dijon, France
- Centre Universitaire Hospitalier de Dijon Dijon, France
Completed
Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung
NCT00832780
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Universtiy of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
Completed
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors
NCT03006887
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +25 more
- Locations
-
- Eisai Trial Site 1 Chuo-ku, Tokyo, Japan
NCT02646020
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Cancer Center of Sun-Yat Sen University (CCSYSU) Guangzhou, Guangdong, China
Completed
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
NCT02528357
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT01076231
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00452413
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palo Alto, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Louisville, Kentucky, United States
NCT01199068
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Asan Medical Center Seoul, Songpa-Gu, South Korea